Sturniolo Isotta

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2019-2024

2024

Sturniolo, I., Váróczy, C., Regdon, Z., Türk-Mázló, A., Muzsai, S., Bácsi, A., Intili, G., Hegedűs, C., Boothby, M. R., Holechek, J., Ferraris, D., Schüler, H., Virág, L.: PARP14 contributes to the development of the tumor-associated macrophage phenotype.
Int. J. Mol. Sci. 25 (7), 1-21, (article identifier: 3601), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

Sturniolo, I., Váróczy, C., Bede, Á. M., Hegedűs, C., Demény, M. Á., Virág, L.: Quantifying antibody-dependent cellular cytotoxicity in a tumor spheroid model: application for drug discovery.
J. Vis. Exp. 206, 1-14, (article identifier: 65922), 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Chemical Engineering (miscellaneous)

Q3 Immunology and Microbiology (miscellaneous)

Q3 Neuroscience (miscellaneous)

2022

Guti, E., Regdon, Z., Sturniolo, I., Kiss, A., Kovács, K., Demény, M. Á., Szöőr, Á., Vereb, G., Szöllősi, J., Hegedűs, C., Polgár, Z., Virág, L.: The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer Immunol. Immunother. 71 (9), 2151-2168, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Cancer Research

Q1 Immunology

Q1 Immunology and Allergy

D1 Medicine (miscellaneous)

Q1 Oncology

2020

Kiss, A., Ráduly, A. P., Regdon, Z., Polgár, Z., Tarapcsák, S., Sturniolo, I., El-Hamoly, T., Virág, L., Hegedűs, C.: Targeting nuclear NAD+ synthesis inhibits DNA repair, impairs metabolic adaptation increases chemosensitivity of U-2OS osteosarcoma cells.
Cancers (Basel). 12 (5), 1-27, 2020.

DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

2019

Kumar, J., Murugaiah, V., Sotiriadis, G., Kaur, A., Jeyaneethi, J., Sturniolo, I., Alhamlan, F. S., Chatterjee, J., Hall, M., Kishore, U., Karteris, E.: Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer.
Front Oncol. 9, 1-14, (article identifier: 542), 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology